Taurine for multiple sclerosis: a study on safety and effectiveness
Part of Brain & nervous system, Immune system & allergy clinical trials.
This trial tests if adding taurine to your current multiple sclerosis treatment is safe and helpful. It is for adults with MS who are already on a stable disease-modifying therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been diagnosed with multiple sclerosis using current standards.
- You have been on a stable disease-modifying therapy before joining the study.
- Your disability level is mild to moderate (an EDSS score between 1.0 and 5.5).
- You are not pregnant or breastfeeding and agree to use effective birth control if needed.
- You are willing and able to follow all study procedures and visit schedules.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests whether taking taurine affects blood sugar control, cholesterol/fats, and inflammation in people with type 2 diabetes. It may help by improving these lab markers, which are linked to long-term health risks.
This study tests whether N-acetyl cysteine (a supplement-like medicine) changes body and brain function in people with multiple sclerosis. It may help researchers understand how it affects brain chemistry and activity using special brain imaging.
This trial tests if taurine, a natural supplement, can help teenagers who still have symptoms like fatigue or brain fog months after a COVID infection. It aims to see if taking taurine reduces these lingering symptoms.
This study tests whether taking a taurine supplement can help your muscles work longer before getting tired. Researchers will use a light sensor on your leg to see how muscles use oxygen.
This trial tests whether adding a Chinese herbal formula (Yishen Daluo Yin) to standard multiple sclerosis medications helps manage the disease better. It may be an option if you have relapsing MS and are stable on a first-line drug.
This study tests whether adding a probiotic supplement to your usual MS treatment (or to no treatment) can help manage relapsing-remitting multiple sclerosis. It aims to see if the probiotic is safe and beneficial as an add-on therapy.
Hear when a new Multiple Sclerosis (MS) - Relapsing-remitting trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.